Heart disease remains a major cause of morbidity, hospitalizations, and mortality, particularly in women. Women experience a higher symptom burden than men, are more frequently misdiagnosed, and are underrepresented in clinical trials for health failure treatment. To address these gaps, PlatformQ Health and the American Society for Preventive Cardiology launched a virtual CME program covering:

  • Heart Failure: Exploring Gender Differences in its Presentation and Management
  • Reducing Mortality and Hospitalization in Heart Failure: Research Updates & Novel Treatments for HFpEF and HFrEF

The program’s outcomes were accepted as a publication of a poster at the Heart Failure Society of America Annual Scientific Meeting 2021.


The program’s sessions included a two-hour video, produced and broadcast live on CardioCareLive.com, and featured educational slides, panel discussions, live polling, and Q&A. 

More than 1,276 learners engaged with the education, including physicians and advanced practitioner providers. Responses from CME, live polling, and pre- and post-course attendance were evaluated to assess the effectiveness of the learning.

At two months after the course, 65% of learners reported that the education has provided a positive impact on patient outcomes and 68% reported a positive impact on clinical practice. 83 learners also shared qualitative examples of changes in improving the assessment of women with heart failure symptoms as well as the ability to use newer agents in managing the condition.

In light of these findings, the organizations see the value in ongoing education on related topics, such as the mechanisms of action of newer therapies, enhanced management of obesity and diabetes, and optimizing patient adherence. 

Have questions about the posters or want to learn more about how PlatformQ Health is delivering impactful education to HCPs and patients? Email us at digital@platformq.com